PSTV - Plus Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-07-22    (Delayed quote data   2025-05-09)
Last
 0.66		 Change
 ⇑ +0.04   (+0.00%)		 Volume
  916,269
Open
 0.64		 High
 0.67		 Low
 0.59
8EMA (Daily)
 0.65		 40EMA (Daily)
 0.81		 50EMA (Daily)
 0.85		 STO (Daily)
 11.661		 MACD Hist (Daily)
 -0.012
8EMA (Weekly)
 0.794		 40EMA (Weekly)
 1.21		 50EMA (Weekly)
 1.35		 STO (Weekly)
 22.319		 MACD Hist (Weekly)
 -0.057
Company Profile
Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com